# Neil Thomas > Neil Thomas is a startup investor at Ventac Partners (Madrid). See 0 investments, check sizes, portfolio and contact details. Updated Aug 2026. - Type: Angel Investor - Fund: Ventac Partners - Location: Madrid, Spain - Last updated: Aug 2026 - LinkedIn: https://es.linkedin.com/in/drneilt Neil Thomas is a startup investor at Ventac Partners in Madrid. Dr Neil Thomas joined Ventac Partners in March 2012. Dr. Neil Thomas has worked in the protection and commercial exploitation of academic and industrial intellectual property in the biotechnology sector since 1997, within both legal and business environments. Dr. Thomas brings extensive experience in company formation, patent drafting, patentportfolio management, business development, licensing and technology exploitation.Prior to joining Ventac Partners, Dr. Thomas was Director of Business Development & IP at Genetrix, a biotechnology fund in Madrid, Spain. Dr. Thomas was responsible for IP, business development, licensing, and fund raising assistance for the group's 10 companies, including the IP and licensing elements of two €27M VC funding rounds for Cellerix SA (now TiGenix NV) and a large product licensing deal for that same company with Axcan Pharma, Inc. Dr. Thomas was also responsible for the successful sale of Genetrix group company Imbiosis SL to R-Biopharm AG. He established and ran a business development subsidiary of the group, Genetrix Life Sciences AB, based in Uppsala, Sweden, of which he was the sole representative and a member of the board. He also sat on the boards of group companies Biobide SL and Sensia SL.Other experience includes four years working at Roche spin-out bioXell SpA. in Milan, Italy, where he was Director of IP & Technology, expanding the company patent portfolio from 6 to 35 patent families, contributing to the company’s successful IPO. He also managed the IP and licensing aspects of three VC funding rounds totaling €50.5M and worked on a deal with a Top-5 pharmaceutical company having a potential value of US$150M and involving a package of patents he had drafted and managed. Prior to that, Dr. Thomas worked for six years in London-based European Patent Attorney firms, advising academic and industrial clients in the biotechnology and pharmaceutical sectors.Dr. Thomas is the Adjunct Professor of Intellectual Property in the Life Sciences Industry at the IE Business School, Madrid, a Member of the Licensing Executives Society and an Associate of the UK's Chartered Institute of Patent Attorneys.Dr. Thomas holds a Bachelor’s Degree in Biological Sciences from the University of Birmingham, UK and a PhD in Biochemistry and Molecular Biology from the University of Durham, UK ## Contacts 5 contacts available for Neil Thomas: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/neil-thomas-3?utm_source=investor_profile ## About Ventac Partners VC Fund 1 contacts available at Ventac Partners. | Name | Title | Profile | | --- | --- | --- | | Neil Thomas | Partner | https://shizune.co/investors/profile/neil-thomas-3 | ## FAQ ### How do I contact Neil Thomas? Public channels for Neil Thomas include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox. ### Is Shizune's investor data accurate? Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page. # About Shizune Shizune.co is an investor database. Core features: - 48,091 startup investors (angels, VCs, accelerators, and others) - Email, phone, LinkedIn (for intros), socials, and other contact data - Updated daily from public funding news - CSV and Excel export The User can access the full database FOR FREE after signing up: shizune.co